Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $18.4450 (-2.69%) ($18.4450 - $18.4450) on Fri. Jan. 29, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.18% (three month average) | RSI | 32 | Latest Price | $18.4450(-2.69%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | ATRA declines -1.2% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(53%) ARKG(45%) IBB(45%) ARKK(44%) IWO(44%) | Factors Impacting ATRA price | ATRA will decline at least -2.09% in a week (0% probabilities). VIXM(-34%) VXX(-27%) UNG(-10%) UUP(-9%) TLT(-9%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.09% (StdDev 4.18%) | Hourly BBV | -1.5 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | Resistance Level | $19.13 | 5 Day Moving Average | $19.03(-3.07%) | 10 Day Moving Average | $18.78(-1.78%) | 20 Day Moving Average | $19.13(-3.58%) | To recent high | -29.9% | To recent low | 45.5% | Market Cap | $1.371b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |